BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30721584)

  • 21. Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction.
    Henzler T; Roeger S; Meyer M; Schoepf UJ; Nance JW; Haghi D; Kaminski WE; Neumaier M; Schoenberg SO; Fink C
    Eur Respir J; 2012 Apr; 39(4):919-26. PubMed ID: 21965223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma brain natriuretic Peptide as a predictive marker of early recurrent stroke in cardioembolic stroke patients.
    Shibazaki K; Kimura K; Aoki J; Sakai K; Saji N; Uemura J
    J Stroke Cerebrovasc Dis; 2014; 23(10):2635-2640. PubMed ID: 25238924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke.
    Rodríguez-Yáñez M; Sobrino T; Blanco M; de la Ossa NP; Brea D; Rodríguez-González R; Leira R; Dávalos A; Castillo J
    Dis Markers; 2009; 26(4):189-95. PubMed ID: 19729800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N
    Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
    Hong SN; Ahn Y; Hwang SH; Yoon NS; Lee SR; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Aug; 100(4):631-4. PubMed ID: 17697819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could pro-BNP, uric acid, bilirubin, albumin and transferrin be used in making the distinction between stroke subtypes?
    Cojocaru IM; Cojocaru M; Sapira V; Ionescu A; Bârlan S; Tacu N
    Rom J Intern Med; 2013; 51(3-4):188-95. PubMed ID: 24620632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill.
    Li G; Daniels CE; Kojicic M; Krpata T; Wilson GA; Winters JL; Moore SB; Gajic O
    Transfusion; 2009 Jan; 49(1):13-20. PubMed ID: 18954397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope.
    Pfister R; Hagemeister J; Esser S; Hellmich M; Erdmann E; Schneider CA
    Int J Cardiol; 2012 Mar; 155(2):268-72. PubMed ID: 21056483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.
    Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H
    J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BNP on Admission Combined with Imaging Markers of Multimodal CT to Predict the Risk of Cardioembolic Stroke.
    Cao R; Jiang Y; Li L; Lu Y; Wang J; Yu K; Chen M; Chen J
    Dis Markers; 2022; 2022():3327967. PubMed ID: 35928924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
    Meyer B; Huelsmann M; Wexberg P; Delle Karth G; Berger R; Moertl D; Szekeres T; Pacher R; Heinz G
    Crit Care Med; 2007 Oct; 35(10):2268-73. PubMed ID: 17717488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study.
    Barbieri A; Giuliani E; Carone C; Pederzoli F; Mascheroni G; Greco G; Stucchi C; Genedani S
    Minerva Anestesiol; 2013 Jul; 79(7):750-7. PubMed ID: 23511364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration.
    Ballotta A; Ranucci M; Kunkl A; El Baghdady H; Bossone E; Castelvecchio S; Frigiola A; Menicanti L; Di Donato M; Mehta RH
    Am J Cardiol; 2010 Mar; 105(5):640-4. PubMed ID: 20185010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery.
    Kerbaul F; Collart F; Giorgi R; Oddoze C; Lejeune PJ; Guidon C; Caus T; Bellezza M; Gouin F
    Intensive Care Med; 2004 Sep; 30(9):1799-806. PubMed ID: 15138672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.